SN - Smith & Nephew plc
LSE
->
Healthcare
->
Medical Devices
Watford,
United Kingdom
Type: Equity
SN price evolution
SN
| (in millions $) | 29 Jun 2024 | 29 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $568 | $568 | $302 | $302 |
| Short term investments | ||||
| Net receivables | $1399 | $1399 | $1333 | $1333 |
| Inventory | $2491 | $2491 | $2395 | $2395 |
| Total current assets | $4458 | $4458 | $4030 | $4030 |
| Long term investments | $24 | $24 | $24 | $24 |
| Property, plant & equipment | $1441 | $1441 | $1470 | $1470 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $10542 | $10542 | $9987 | $9987 |
| Current liabilities | ||||
| Accounts payable | $1024 | $1024 | $1055 | $1055 |
| Deferred revenue | ||||
| Short long term debt | $380 | $380 | $765 | $765 |
| Total current liabilities | $1777 | $1777 | $2271 | $2271 |
| Long term debt | $3275 | $3275 | $2319 | $2319 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $5337 | $5337 | $4770 | $4770 |
| Shareholders' equity | ||||
| Retained earnings | $4934 | $4934 | $4906 | $4906 |
| Other shareholder equity | -$437 | -$437 | -$385 | -$385 |
| Total shareholder equity | $5205 | $5205 | $5217 | $5217 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $302 | $350 | $1290 | $1762 |
| Short term investments | ||||
| Net receivables | $1333 | $1178 | $1290 | $1106 |
| Inventory | $2395 | $2205 | $1844 | $1691 |
| Total current assets | $4030 | $3856 | $4424 | $4664 |
| Long term investments | $24 | $58 | $198 | $117 |
| Property, plant & equipment | $1470 | $1455 | $1513 | $1449 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $9987 | $9966 | $10920 | $11012 |
| Current liabilities | ||||
| Accounts payable | $1055 | $1029 | $1096 | $891 |
| Deferred revenue | ||||
| Short long term debt | $765 | $160 | $491 | $337 |
| Total current liabilities | $2271 | $1715 | $2131 | $1688 |
| Long term debt | $2319 | $2712 | $2848 | $3353 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $4770 | $4707 | $5352 | $5733 |
| Shareholders' equity | ||||
| Retained earnings | $4906 | $5026 | $4897 | $4647 |
| Other shareholder equity | -$385 | -$439 | -$328 | |
| Total shareholder equity | $5217 | $5259 | $5568 | $5279 |
| (in millions $) | 29 Jun 2024 | 29 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1413.5 | $1413.5 | $1407.5 | $1407.5 |
| Cost of revenue | $426.5 | $426.5 | $447 | $447 |
| Gross Profit | $987 | $987 | $960.5 | $960.5 |
| Operating activities | ||||
| Research & development | $68.5 | $68.5 | $86.5 | $86.5 |
| Selling, general & administrative | $754.5 | $754.5 | $799 | $799 |
| Total operating expenses | $1249.5 | $1249.5 | $1332.5 | $1332.5 |
| Operating income | $164 | $164 | $75 | $75 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $19.5 | $19.5 | -$6 | -$6 |
| Interest expense | -$35 | -$35 | -$35 | -$35 |
| Net income | ||||
| Net income | $107 | $107 | $45.5 | $45.5 |
| Income (for common shares) | $107 | $107 | $45.5 | $45.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5549 | $5215 | $5212 | $4560 |
| Cost of revenue | $1730 | $1540 | $1543 | $1375 |
| Gross Profit | $3819 | $3675 | $3669 | $3185 |
| Operating activities | ||||
| Research & development | $339 | $345 | $356 | $279 |
| Selling, general & administrative | $3055 | $2880 | $2377 | $2160 |
| Total operating expenses | $5124 | $4765 | $4544 | $4265 |
| Operating income | $425 | $668 | $295 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $27 | $12 | $62 | -$202 |
| Interest expense | -$132 | -$80 | ||
| Net income | ||||
| Net income | $263 | $223 | $524 | $448 |
| Income (for common shares) | $263 | $223 | $524 | $448 |
| (in millions $) | 29 Jun 2024 | 29 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $107 | $107 | $45.5 | $45.5 |
| Operating activities | ||||
| Depreciation | $52.5 | $52.5 | $80 | $80 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $119 | $119 | $247.5 | $247.5 |
| Investing activities | ||||
| Capital expenditures | -$86 | -$86 | -$130 | -$130 |
| Investments | ||||
| Total cash flows from investing | -$180 | -$180 | -$133 | -$133 |
| Financing activities | ||||
| Dividends paid | -$101 | -$101 | -$63 | -$63 |
| Sale and purchase of stock | $0.5 | $0.5 | -$0.5 | -$0.5 |
| Net borrowings | $286.5 | $286.5 | $2.5 | $2.5 |
| Total cash flows from financing | $186 | $186 | -$57 | -$57 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $122.5 | $122.5 | $58.5 | $58.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $263 | $223 | $586 | $246 |
| Operating activities | ||||
| Depreciation | $355 | $319 | $581 | $562 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $608 | $468 | $877 | $935 |
| Investing activities | ||||
| Capital expenditures | -$427 | -$358 | -$408 | -$443 |
| Investments | ||||
| Total cash flows from investing | -$448 | -$472 | -$691 | -$606 |
| Financing activities | ||||
| Dividends paid | -$327 | -$327 | -$329 | -$328 |
| Sale and purchase of stock | -$152 | $14 | -$5 | |
| Net borrowings | $123 | -$450 | -$326 | $1490 |
| Total cash flows from financing | -$200 | -$926 | -$645 | $1164 |
| Effect of exchange rate | -$7 | $1 | ||
| Change in cash and equivalents | -$44 | -$941 | -$466 | $1494 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $5.64B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $305.00M |
| Revenue Q/Q | 3.40% |
| Revenue Y/Y | 5.48% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 2.97% |
| ROE | 5.85% |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.51 |
| Quick ratio | 1.11 |